胸肌前与胸肌后两阶段乳房再造:30天并发症与长期结局的倾向评分匹配分析
该回顾性研究纳入2011年1月至2020年12月接受即刻两阶段植入物乳房再造的女性患者,经倾向评分匹配后分析154例再造(每组77例),比较胸肌前与胸肌后入路的30天并发症、一、二期并发症及术后放疗启动时间。结果显示两组并发症率无显著差异,胸肌前组引流管拔除时间更短、术中扩张量更高,放疗启动时间无显著差异。
要点
- 匹配后每组77例再造,两组30天及一、二期并发症率无显著差异。
- 胸肌前组引流管拔除中位时间13天 vs 胸肌后组15天(p=0.001)。
- 两组术后放疗启动时间无显著差异(134天 vs 126.5天,p=0.58)。
核心结论
- 胸肌前与胸肌后组织扩张器置入在两阶段植入物乳房再造的一期和二期并发症率相当。
- 两种入路的组织扩张器更换为植入物时机及术后放疗启动时间相当。
研究设计与样本
- 回顾性病历审查,时间范围为2011年1月至2020年12月。
- 纳入接受即刻两阶段植入物乳房再造的女性患者,采用倾向评分匹配。
- 匹配后分析154例再造,胸肌前组77例、胸肌后组77例。
主要发现
- 匹配后两组所有分析的人口学及术中独立变量特征相当(p > 0.05)。
- 胸肌前组引流管拔除中位时间13天 vs 胸肌后组15天(p = 0.001)。
- 胸肌前组术中扩张量300 ml vs 胸肌后组200 ml(p = 0.025)。
- 两组30天并发症率及一、二期并发症率无显著差异。
- 术后放疗启动时间两组无显著差异(134天 vs 126.5天,p = 0.58)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 80% of patients undergoing total mastectomy in the US opt for implant-based breast reconstruction (IBBR). A two-stage reconstruction with tissue expander (TE) remains the most common technique. Since the implementation of ADMs, a prepectoral approach has gained popularity and is becoming the standard of care. Herein, we compared the surgical and postoperative outcomes of prepectoral versus subpectoral two-stage IBBR. METHODS: A retrospective chart review was performed between January 2011 and December 2020. We included female patients undergoing immediate two-stage IBBR. The primary outcomes of this study were to compare the 30-day morbidity and the overall rate of complications during the first and second stages of reconstruction, and to compare the time to initiate postmastectomy radiotherapy (PMRT). Propensity score matching was implemented. RESULTS: After matching, 154 reconstructions were analyzed, 77 in each group. The two matched groups exhibited comparable (p > 0.05) characteristics for all analyzed demographic and intraoperative independent variables. Reconstructions in the prepectoral group had a shortened median time for drain removal (13-days vs. 15-days, p = 0.001). The intraoperative expansion volumes were higher in the prepectoral group (300 ml versus 200 ml, p = 0.025). The 30-day morbidity and first- and second-stage complication rates were not significantly different between groups. The time to start postmastectomy radiation therapy (PMRT) was not significantly different between groups (134-days versus 126.5-days, p = 0.58). CONCLUSION: Prepectoral and subpectoral TE placement had comparable complication rates during the first and second stages of IBBR. Timing for TE-to-Implant exchange and initiation of PMRT were comparable between the two approaches.
引用
- Escandón JM, Sweitzer K, Christiano JG, et al. Subpectoral versus prepectoral two-stage breast reconstruction: A propensity score-matched analysis of 30-day morbidity and long-term outcomes. J Plast Reconstr Aesthet Surg. 2022. PMID: 36513014. doi:10.1016/j.bjps.2022.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。